GDOC vs. PBE ETF Comparison

Comparison of Goldman Sachs Future Health Care Equity ETF (GDOC) to PowerShares Dynamic Biotech & Genome (PBE)
GDOC

Goldman Sachs Future Health Care Equity ETF

GDOC Description

Goldman Sachs Future Health Care Equity ETF is an exchange traded fund launched and managed by Goldman Sachs Asset Management, L.P. The fund invests in the public equity markets across the globe. It invests in stocks of companies operating across health care including genomics, precision medicine, technology-enabled procedures, and digital healthcare sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund employs fundamental analysis and quantitative with to create its portfolio. It seeks to benchmark the performance of its portfolio against the MSCI ACWI Health Care Index. The fund employs proprietary research to create its portfolio. Goldman Sachs Future Health Care Equity ETF was formed on November 9, 2021 and is domiciled in the United States.

Grade (RS Rating)

Last Trade

$33.56

Average Daily Volume

1,009

Number of Holdings *

35

* may have additional holdings in another (foreign) market
PBE

PowerShares Dynamic Biotech & Genome

PBE Description The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$64.06

Average Daily Volume

17,493

Number of Holdings *

30

* may have additional holdings in another (foreign) market
Performance
Period GDOC PBE
30 Days -1.74% 1.23%
60 Days -2.52% -3.98%
90 Days 0.69% -0.07%
12 Months 1.89% 2.88%
6 Overlapping Holdings
Symbol Grade Weight in GDOC Weight in PBE Overlap
AMGN A 3.58% 4.94% 3.58%
BIIB D 2.87% 4.9% 2.87%
BMRN F 3.08% 4.75% 3.08%
ITCI C 0.39% 2.62% 0.39%
NBIX A 2.74% 5.3% 2.74%
XENE C 0.48% 2.44% 0.48%
GDOC Overweight 29 Positions Relative to PBE
Symbol Grade Weight
LLY D 10.01%
BSX A 6.19%
ISRG C 4.53%
DHR C 3.67%
ZBH D 3.38%
PODD D 3.04%
BMY F 2.53%
MTD D 2.24%
ABBV D 2.17%
A C 1.99%
DXCM D 1.93%
IDXX F 1.78%
SWAV A 1.74%
HUM F 1.47%
ALGN F 1.42%
WST F 1.35%
EXAS F 1.31%
VEEV D 1.31%
EW D 1.18%
ARGX D 1.0%
GMAB D 0.74%
ALNY D 0.67%
RARE D 0.62%
IRTC C 0.53%
NTRA A 0.52%
ILMN F 0.49%
STVN F 0.47%
DYN D 0.4%
PCVX D 0.39%
GDOC Underweight 24 Positions Relative to PBE
Symbol Grade Weight
TECH C -5.41%
REGN B -4.98%
VRTX D -4.79%
GILD F -4.56%
PTCT B -3.55%
TGTX C -3.41%
MNKD D -3.34%
UTHR A -3.31%
BPMC A -3.22%
COLL C -3.21%
HALO D -3.03%
CPRX D -2.99%
EXEL D -2.94%
CLDX C -2.91%
QGEN C -2.74%
IONS F -2.67%
VCEL C -2.65%
DVAX D -2.62%
RGEN D -2.28%
MYGN D -2.24%
VCYT D -2.21%
FOLD F -2.09%
EYPT D -1.97%
ACAD F -1.89%
Compare ETFs